1. Assessment of an onco-sexology support and follow-up program in cervical or vaginal cancer patients undergoing brachytherapy.
- Author
-
Kpoghomou MA, Geneau M, Menard J, Stiti M, Almont T, Ghose B, Attal J, Delannes M, Huyghe E, and Ducassou A
- Subjects
- Adult, Aged, Aged, 80 and over, Carcinoma in Situ radiotherapy, Constriction, Pathologic epidemiology, Constriction, Pathologic etiology, Dilatation, Female, Follow-Up Studies, Humans, Middle Aged, Nurses, Patient Compliance, Prospective Studies, Retrospective Studies, Sexology methods, Brachytherapy adverse effects, Psychosocial Support Systems, Sexual Behavior psychology, Sexuality statistics & numerical data, Uterine Cervical Neoplasms radiotherapy, Vaginal Neoplasms radiotherapy
- Abstract
Purpose: Women's sexual health and wellbeing with cervical or vaginal cancer may be largely affected by complications from external beam radiotherapy (EBRT) and utero-vaginal brachytherapy (BT), of which vaginal stenosis is the main complication. The objective of this study was to assess the impact of support by a nurse sexologist on sexuality, vaginal side-effects, and the quality of clinical follow-up in patients treated with brachytherapy for cervical or vaginal cancer., Methods: We performed a retrospective study of the sexuality of women treated for cervical or vaginal cancer. Data from patients with cervical or vaginal cancer who underwent brachytherapy between 2013 and 2017 were collected at Institut Universitaire de Cancer de Toulouse-Oncopôle (IUCT-Oncopôle). Patients were divided into two groups: group A (intervention group) received support from a nurse sexologist and group B (control group) did not. The chi-square test and a logistic multivariate model were used for data analysis., Results: A total of 156 patients were included in this study, including 57.7% who were followed by a nurse sexologist. We observed low compliance in using vaginal dilators after brachytherapy and/or radiotherapy over time regardless of the group, and patients' sexual activity was inadequately addressed. Information regarding the resumption of sexuality 2 months after treatment was missing in 1.1% of patients in group A and in 36.4% of patients in group B. Multivariate analysis showed that patients in group A had a lower risk of developing vaginal stenosis with OR
crude = 0.5 (95% CI = 0.25-0.92) and ORadj . = 0.5 (95% CI = 0.26-1.09) compared with those in group B., Conclusion: This retrospective study highlights the lack of information collected by physicians during follow-up concerning the sexuality of patients with cervical or vaginal cancer treated by EBRT and BT. The support offered by nurse sexologists in improving patients' sexual activity and reducing their physical side-effects such as vaginal stenosis is likely to be beneficial. A prospective study is currently being conducted to validate the present findings.- Published
- 2021
- Full Text
- View/download PDF